BAB is delighted to host a virtual roundtable featuring with Faisal Khalid, Head of Healthcare Banking, Santander, N.A. and Susan Schriver, who lead’s Boston Consulting Group’s commercial biopharma work globally with a focus on commercial and corporate strategy issues. The speakers will lead a discussion on emerging trends in the life sciences sector and pharma industry.
The discussion will cover:
- How the COVID-19 pandemic has impacted & changed strategies, as well as response & delivery approaches in life sciences;
- How the market is shifting, and what forces will shape the industry in the next 5 years;
- Emerging trends in life sciences, including digital transformation, industry-changing R&D developments and novel medical innovations, and changes to the model of consumer engagement, and the move towards convergence & consolidation.
By way of background, BAB’s executive roundtable series regularly features some of the world’s leading chairs and chief executives who we invite to lead a discussion for a group of around 25 senior business leaders on key issues of importance to British and American business. The event operates under Chatham House Rule and provides a valuable opportunity for dialogue amongst global business and government leaders.